Frontlight ResearchEarly access
CompletedNo phase
HSAT for OSA Management in Children
Key facts
- Who runs it
- Children's Hospital of Philadelphia
- Where
- Philadelphia, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 62 people enrolled
- Started
- 1 Dec 2022
- Ended
- 17 Sept 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Home sleep apnea test
- PSG
- Record updated
- 14 October 2025
Who can take part
- Age
- 5 years to 12 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Male and female children age 5-12 years old inclusive
- History of adenotonsillectomy for OSA
Who cannot take part
- Children with a history of hypoventilation or hypoxemia or who require supplemental oxygen or positive airway pressure during sleep
- Children with a tracheostomy or tracheocutaneous fistula
- Children who live in a facility without their parent
Where in United States
- Children's Hospital of PhiladelphiaPhiladelphia, United States
About the trial
What the trial wants to find out
This clinical trial will compare the diagnostic accuracy of type II HSAT with PSG for determining OSA status following treatment with adenotonsillectomy in children
The 2 groups in the trial
- HSAT prior to clinical sleep studyTreatment being tested
Participants will be randomized to undergo HSAT before receiving their clinical, in-lab polysomnography
Treatment: Home sleep apnea test
- PSG first Participants will be randomExisting treatment, for comparison
Participants will be randomized to undergo HSAT after receiving their clinical, in-lab polysomnography.
Treatment: PSG
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Home Sleep Apnea Testing for the Evaluation of Obstructive Sleep Apnea in Children Following Management With Adenotonsillectomy
- Record updated
- 14 October 2025